Is COVID-19 severity associated with reduction in T lymphocytes in anti-CD20-treated people with Multiple Sclerosis or Neuromyelitis Optica Spectrum Disorder?

Hoepner, Robert; Kamm, Christian; Friedli, Christoph; Salmen, Anke; Chan, Andrew (2022). Is COVID-19 severity associated with reduction in T lymphocytes in anti-CD20-treated people with Multiple Sclerosis or Neuromyelitis Optica Spectrum Disorder? CNS neuroscience & therapeutics, 28(6), pp. 971-973. Wiley 10.1111/cns.13841

[img]
Preview
Text
CNS_Neuroscience_Therapeutics_-_2022_-_Hoepner_-_Is_COVID_19_severity_associated_with_reduction_in_T_lymphocytes_in.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (583kB) | Preview

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Department of Head Organs and Neurology (DKNS) > Clinic of Neurology

UniBE Contributor:

Hoepner, Robert, Kamm, Christian Philipp, Friedli, Christoph Daniel, Salmen, Anke, Chan, Andrew Hao-Kuang

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1755-5949

Publisher:

Wiley

Language:

English

Submitter:

Pubmed Import

Date Deposited:

13 Apr 2022 09:27

Last Modified:

05 Dec 2022 16:18

Publisher DOI:

10.1111/cns.13841

PubMed ID:

35411701

BORIS DOI:

10.48350/169273

URI:

https://boris.unibe.ch/id/eprint/169273

Actions (login required)

Edit item Edit item
Provide Feedback